Stock Research for ARWR

ARWR

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ARWR Stock Chart & Research Data

The ARWR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ARWR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ARWR Due diligence Resources & Stock Charts

The ARWR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ARWR Detailed Price Forecast - CNN Money CNN View ARWR Detailed Summary - Google Finance
Yahoo View ARWR Detailed Summary - Yahoo! Finance Zacks View ARWR Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ARWR Trends & Analysis - Trade-Ideas Barrons View ARWR Major Holders - Barrons
NASDAQ View ARWR Call Transcripts - NASDAQ Seeking View ARWR Breaking News & Analysis - Seeking Alpha
Spotlight View ARWR Annual Report - CompanySpotlight.com OTC Report View ARWR OTC Short Report - OTCShortReport.com
TradeKing View ARWR Fundamentals - TradeKing Charts View ARWR SEC Filings - Bar Chart
WSJ View Historical Prices for ARWR - The WSJ Morningstar View Performance/Total Return for ARWR - Morningstar
MarketWatch View the Analyst Estimates for ARWR - MarketWatch CNBC View the Earnings History for ARWR - CNBC
StockMarketWatch View the ARWR Earnings - StockMarketWatch MacroAxis View ARWR Buy or Sell Recommendations - MacroAxis
Bullish View the ARWR Bullish Patterns - American Bulls Short Pains View ARWR Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ARWR Stock Mentions - StockTwits PennyStocks View ARWR Stock Mentions - PennyStockTweets
Twitter View ARWR Stock Mentions - Twitter Invest Hub View ARWR Investment Forum News - Investor Hub
Yahoo View ARWR Stock Mentions - Yahoo! Message Board Seeking Alpha View ARWR Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ARWR - SECform4.com Insider Cow View Insider Transactions for ARWR - Insider Cow
CNBC View ARWR Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ARWR - OTC Markets
Yahoo View Insider Transactions for ARWR - Yahoo! Finance NASDAQ View Institutional Holdings for ARWR - NASDAQ


Stock Charts

FinViz View ARWR Stock Insight & Charts - FinViz.com StockCharts View ARWR Investment Charts - StockCharts.com
BarChart View ARWR Stock Overview & Charts - BarChart Trading View View ARWR User Generated Charts - Trading View




Latest Financial News for ARWR


Turnstone Biologics Appoints William Waddill to its Board of Directors
Posted on Tuesday April 16, 2024

SAN DIEGO, April 16, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy, today announced the appointment of industry veteran William Waddill to the Company’s Board of Directors. The Company also announced that Patrick Machado has stepped down as a member o


Institutional investors may adopt severe steps after Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) latest 6.6% drop adds to a year losses
Posted on Tuesday April 16, 2024

Key Insights Significantly high institutional ownership implies Arrowhead Pharmaceuticals' stock price is sensitive to...


Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo
Posted on Sunday April 07, 2024

PASADENA, Calif., April 07, 2024--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today presented final data from the double-blind treatment period of its Phase 2 SHASTA-2 study of investigational plozasiran (formerly ARO-APOC3) in patients with severe hypertriglyceridemia (SHTG). Results from the SHASTA-2 study showed dramatic, consistent, and sustained reductions in Apolipoprotein C-III (APOC3) and triglycerides and improvement in multiple atherogenic lipoprotein levels. These data were present


Insider Sell: Chief Discovery/Trans Medicine James Hamilton Sells 6,000 Shares of Arrowhead ...
Posted on Wednesday April 03, 2024

James Hamilton, Chief Discovery and Translational Medicine Officer at Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR), sold 6,000 shares of the company on April 1, 2024, according to a recent SEC filing.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.